H-A GLP-1(7-36)NH2 H-A GLP-1(9-36)NH2 + DPP IV cleavage site of DPP-IV H A E G T F T S D V S S Y L E G Q A A K E F I A W L V K G R P S S G A P P P S H G E G T F T S D L S K Q M E E E A V R L F I E W L K N G G GLP-1(7-36)NH2 Exendin-4 Metabolism of GLP-1 by DPP-4 GLP-1/saline infusion GLP-1(9-36)NH2 and insulin secretion Vahl et al., JCEM 2003 Actions of GLP-1 that Regulate Blood Glucose Concentrations Stimulate -cell function - insulin secretion/synthesis - cell growth/antiapoptosis Inhibit glucagon release Delay gastric emptying Diminish food intake Extrapancreatic effects on glucose - promote glucose uptake - suppress HGP Interruption of GLP-1r signaling causes glucose intolerance Scrocchi et al Nature Med, 1996 DAlessio et al JCI, 1996 Edwards et al Diabetes, 1999 Incretin effect of GLP-1 in healthy humans Glucose GIR Insulin C-peptide M Salehi et al, JCEM, 2008 Effects of GLP-1r blockade on meal-induced glucagon release and gastric emptying Glucagon Gastric Emptying M Salehi, JCEM 2008

As more research emerges and more data becomes available, guidelines will continue to evolve
While there remains debate about the ability of non-Semaglutide products to impact GLP-1 enough to drive meaningful weight loss, they could prove helpful to those looking to improve their overall health or help the millions of projected GLP-1 users maintain their weight loss.
Ochsner inspires healthier lives and stronger communities through our mission to serve, heal, lead, educate and innovate
better for higher-mg draws that would exceed one syringe at 5 mg/mL